Priority Date: 29.11.11 (FR 20110060902)

PHACETOPERANE FOR THE TREATMENT OF ATTENTION-DEFICIT HYPERACTIVITY DISORDER

  • Application ID: EP12806593
  • Status: PATENT GRANTED

Applicant

Attorney

operating since 1999
Headquarter in Paris
active in Legal Services and IP Consulting

Specialization

This patent has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY) Cabinet Becker & Associés is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 189 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 29.11.2011 - Priority Date (FR 20110060902)
  • 06.06.2013 - Publication A1 (WO2013079873)
  • 08.10.2014 - Publication A1 (EP2785344)
  • 02.11.2016 - Publication B1 (EP2785344)

IPC Classification